HomeAll New Products Listed Chronologically

All New Products Listed Chronologically

Catalog No. Product Name Information Isotype
E2979 DL-AP5 (2-APV) DL-AP5 (2-APV, DL-2-Amino-5-phosphonovaleric acid) is a competitive antagonist of NMDA (N-methyl-D-aspartate) receptor. It shows significantly antinociceptive activity and specifically blocks on channels in the rabbit retina. Aug 16 2023
E2998 Acetylthiocholine iodide Acetylthiocholine iodide(S-Acetylthiocholine iodide; ATCh iodide) is used as a substrate in the preparation of acetylcholine esterase (AChE) assay working solution for AChE activity assay. In addition, the compound is used in some medical research, for example in the fields of neuroscience and organ physiology. Aug 16 2023
E2997 (+)-Biotin N-hydroxysuccinimide ester (+)-Biotin N-hydroxysuccinimide ester(Biotin-NHS; NHS-Biotin) is an amino reactive biotin reagent used in the preparation of biotinylated surfaces or polypeptides. Aug 16 2023
E2999 Dimethyl pimelimidate dihydrochloride Dimethyl pimelimidate dihydrochloride (DMP) is a homobifunctional amine-reactive crosslinker which is readily hydrolyzed at neutral pH. Aug 16 2023
E4002 Potassium D-gluconate Potassium D-gluconate(Potassium Gluconate) is an orally active carboxylic acid by the oxidation with antiseptic and chelating properties. Aug 16 2023
E4003 N,N'-Methylenebisacrylamide N,N'-Methylenebisacrylamide(Methylenebisacrylamide) is a biochemical,cross-linking agent reagent that can be used as a biological material, during the formation of polymers or organic compound for life science related research. Aug 16 2023
E4004 DL-beta-Hydroxybutyric acid sodium salt DL-beta-Hydroxybutyric acid sodium salt(β-Hydroxybutyric acid sodium) is a metabolite that is elevated in type I diabetes. It can modulate the properties of membrane lipids. Aug 16 2023
E4005 Decamethylcyclopentasiloxane Decamethylcyclopentasiloxane(Cyclomethicone 5) is an organosilicon compound. It is used in cosmetic and personal products as a skin emollient. Aug 16 2023
E4007 L-Sulforaphane L-Sulforaphane ((R)-Sulforaphane) is a highly potent inducer of the Keap1/Nrf2/ARE pathway. It is a more potent inducer of the carcinogen-detoxifying enzyme systems in rat liver and lung than the S-isomer. Aug 15 2023
E2984 GSK-7975A GSK-7975A is a potent and orally available inhibitor of CRAC channel. It reduces FcεRI-dependent Ca2+ influx and reduces the release of histamine, leukotriene C4, and cytokines (IL-5/-8/-13 and TNFα). Aug 15 2023
E4001 Sodium pyrophosphate decahydrate Sodium pyrophosphate decahydrate acts as a buffering agent, a chelator and a hydrated salt nucleating agent. Sodium pyrophosphate decahydrate can also be used to a raw material for synthetic laundry scent additives. Aug 15 2023
E1410 Fluspirilene Fluspirilene(R 6218; Redeptin) is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 μM in cell-free assays. Fluspirileneis a long-acting injectable depot antipsychotic agent used for schizophrenia. Aug 13 2023
E1468 MSU-42011 MSU-42011 is an orally active agonist of retinoid X receptor (RXR). MSU-42011 inhibits the expression of iNOS and p-ERK protein. It exhibits immunomodulatory and antitumor activity. MSU-42011 can be used for cancer research. Aug 13 2023
A2370 Elezanumab (Anti-RGMA) Elezanumab (Anti-RGMA) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway with IC50 of 97 pM. MW: 146.44 kD. Aug 10 2023
A2371 Anti-PVRIG Anti-PVRIG is a humanized, hybridoma monoclonal antibody against the poliovirus receptor-related immunoglobulin (PVRIG; PVR Related Immunoglobulin Domain Containing Protein; CD112R), with potential immune checkpoint inhibitory and antineoplastic activities.MW: 145.5 kD. Aug 10 2023
A2372 Apamistamab (Anti-PTPRC / CD45) Apamistamab (Anti-PTPRC / CD45) is an IgG1 anti-CD45 monoclonal antibody (MoAb). Note: This antibody is not labeled with the radioisotope iodine (-131). MW: 145.5 kD. Aug 10 2023
A2373 Neihulizumab (Anti-PSGL1 / CD162) Neihulizumab (Anti-PSGL1 / CD162) is a humanized, agonistic monoclonal antibody against P selectin glycoprotein ligand-1 (PSGL-1, SELPLG, CD162) with potential immunosuppressive activity. It can halt the progression of T-cell-mediated autoimmune diseases and acute graft-versus-host disease (GvHD). MW: 150 kD. Aug 10 2023
A2374 Crizanlizumab (Anti-P-Selectin / CD62p) Crizanlizumab (Anti-P-Selectin / CD62p) is a humanized monoclonal immunoglobulin G1 anti-P-selectin antibody with vaso-protective and anti-vaso-occlusive properties. MW: 144.24 kD. Aug 10 2023
A2375 Rolinsatamab (Anti-PRLR / Prolactin Receptor) Rolinsatamab (Anti-PRLR / Prolactin Receptor) is a fully humanized bispecific monoclonal antibody that targets IL-4 and IL-13. MW: 145.5 kD. Aug 10 2023
A2378 Rinucumab (Anti-PDGFRB / CD140b) Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD. Aug 10 2023